Biotech & Health Tech
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
The risk appears small and data is mixed, but FDA wants patients to be aware.
This is a summary of the story. Read the full article at Ars Technica ↗